Health-related quality of life of patients with psoriasis: A pilot study in Vietnam

Le Thi Kim Ngan; Dinh Hoang Yen; Pham Thi Thuy Linh; Nguyen Trong Hao

doi:10.59294/HIUJS.VOL.7.2024.685

Từ khóa:

psoriasis, health-related quality of life, Dermatology Life Quality Index, HCMC Hospital of Dermato Venerelogy

Tóm tắt

Background: Psoriasis is a chronic proliferative skin inflammation associated with an immune-allergic mechanism. Long-term treatment regimen and abnormal recurrences may negatively affect the patients' health-related quality of life (HR-QoL). In Vietnam, the HR-QoL of patients with psoriasis has not been fully and comprehensively researched. Objective: Evaluation of HR-QoL of patients with psoriasis and its related factors. Methods: Cross-sectional descriptive study was conducted using the structured 3-part questionnaire, including socio-demographic and clinical characteristics, Dermatology Life Quality Index (DLQI) and visual analogue scale (VAS). Patients with psoriasis treated at Ho Chi Minh City Hospital of Dermato Venerelogy and satisfying inclusion, exclusion criteria were chosen in the study. Face-to-face interview with patients has been conducted from January to March of 2018. Analyzing related factors was performed with relevant statistical tests using 95% confidence interval by SPSS software. Results: Study sample including 310 patients treated at Ho Chi Minh City Hospital of Dermato Venerelogy with the average age of 48.84 ± 16.27 years and 58.39% male. The mean DLQI score was 6.92 ± 3.89 points. Among 6 dimensions of QoL, symptoms and feeling dimension were affected by psoriasis most with the score of 2.99 ± 1.33 (moderate level), followed by treatment dimension (1.77 ± 1.24). Age, living place, occupation, and marital status were related factors to the overall DLQI scores. Limitations: The study did not clarify the relationship of pathological factors with HR-QoL of psoriasis patients. Conclusion: Psoriasis had moderate effect on Vietnamese patient's HR-QoL. Age, living place, occupation, marital status are related factors on the HR-QoL impairment of psoriasis.

Abstract

Background: Psoriasis is a chronic proliferative skin inflammation associated with an immune-allergic mechanism. Long-term treatment regimen and abnormal recurrences may negatively affect the patients' health-related quality of life (HR-QoL). In Vietnam, the HR-QoL of patients with psoriasis has not been fully and comprehensively researched. Objective: Evaluation of HR-QoL of patients with psoriasis and its related factors. Methods: Cross-sectional descriptive study was conducted using the structured 3-part questionnaire, including socio-demographic and clinical characteristics, Dermatology Life Quality Index (DLQI) and visual analogue scale (VAS). Patients with psoriasis treated at Ho Chi Minh City Hospital of Dermato Venerelogy and satisfying inclusion, exclusion criteria were chosen in the study. Face-to-face interview with patients has been conducted from January to March of 2018. Analyzing related factors was performed with relevant statistical tests using 95% confidence interval by SPSS software. Results: Study sample including 310 patients treated at Ho Chi Minh City Hospital of Dermato Venerelogy with the average age of 48.84 ± 16.27 years and 58.39% male. The mean DLQI score was 6.92 ± 3.89 points. Among 6 dimensions of QoL, symptoms and feeling dimension were affected by psoriasis most with the score of 2.99 ± 1.33 (moderate level), followed by treatment dimension (1.77 ± 1.24). Age, living place, occupation, and marital status were related factors to the overall DLQI scores. Limitations: The study did not clarify the relationship of pathological factors with HR-QoL of psoriasis patients. Conclusion: Psoriasis had moderate effect on Vietnamese patient's HR-QoL. Age, living place, occupation, marital status are related factors on the HR-QoL impairment of psoriasis.

Tài liệu tham khảo

[1] S. K. Kurd, Richardson, S. K. and Gelfand, J. M., "Update on the epidemiology and systemic treatment of psoriasis," (in z), Expert review of clinical immunology, vol. 3, no. 2, pp. 171-185, 2007.

DOI: https://doi.org/10.1586/1744666X.3.2.171

[2] D. W. Miller and Feldman, S. R. , "Cost-effectiveness of moderate-to-severe psoriasis treatment," (in y), Expert opinion on pharmacotherapy, vol. 7, no. 2, pp. 157-167, 2006.

DOI: https://doi.org/10.1517/14656566.7.2.157

[3] D. G. Fortune, Richards, H. L. and Griffiths, C. E. , "Psychologic factors in psoriasis: Consequences, mechanisms, and interventions," (in x), Dermatologic clinics, vol. 23, no. 4, pp. 681-694, 2005.

DOI: https://doi.org/10.1016/j.det.2005.05.022

[4] G. Krueger, Koo, J., Lebwohl,… and Rolstad, T. , "The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey," (in w), Archives of Dermatology, vol. 137, no. 3, pp. 280-284, 2001.

[5] H. Devrimci‐Ozguven, Kundakci, … and Boyvat, A. , "The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients," (in v), Journal of the European Academy of dermatology and venereology, vol. 14, no. 4, pp. 267-271, 2000.

DOI: https://doi.org/10.1046/j.1468-3083.2000.00085.x

[6] M. Esposito, Saraceno, R.,… and Chimenti, S. , "An Italian study on psoriasis and depression.," (in u), Dermatology, vol. 212, no. 2, pp. 123-127, 2006.

DOI: https://doi.org/10.1159/000090652

[7] M. A. Gupta, Schork, N. J.,… and Ellis, C. N. , "Suicidal ideation in psoriasis," (in t), International journal of dermatology, vol. 32, no. 3, pp. 188-190, 1993.

DOI: https://doi.org/10.1111/j.1365-4362.1993.tb02790.x

[8] M. J. Bhosle, Kulkarni,… and Balkrishnan, R. , "Quality of life in patients with psoriasis," (in r), Health and quality of life outcomes, vol. 4, no. 1, p. 35, 2006.

DOI: https://doi.org/10.1186/1477-7525-4-35

[9] A. A. Eid and Elweshahi, H. M. , "Quality of life of Egyptian patients with psoriasis: a hospitalbased cross-sectional survey," (in q), Egyptian Journal of Dermatology and Venerology, vol. 36, no. 1, p. 11, 2016.

DOI: https://doi.org/10.4103/1110-6530.194155

[10] E. Martínez-García, Arias-Santiago,… and Buendía-Eisman, A., "Quality of life in persons living with psoriasis patients," (in p), Journal of the American Academy of Dermatology, vol. 71, no. 2, pp. 302-307, 2014.

DOI: https://doi.org/10.1016/j.jaad.2014.03.039

[11] A. Al Raddadi, Jfri, A.,... and Mahdi, A. , "Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment," (in o), Journal of Dermatology & Dermatologic Surgery, vol. 20, no. 1, pp. 15-18, 2016.

DOI: https://doi.org/10.1016/j.jdds.2015.05.002

[12] C. Mørk, Wahl, A. and Moum, T., "The Norwegian version of the dermatology life quality index: A study of validity and reliability in psoriatics," (in n), Acta dermato-venereologica, vol. 82, no. 5, 2002.

DOI: https://doi.org/10.1080/000155502320624078

[13] F. Sampogna, Chren, M. M.,… and Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group. , "Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis," (in m), British journal of dermatology, vol. 154, no. 2, pp. 325-331, 2006.

DOI: https://doi.org/10.1111/j.1365-2133.2005.06909.x

[14] E. Mazzotti, Barbaranelli,… and Pasquini, P. , "Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis," (in l), Acta dermato- venereologica, vol. 85, no. 5, 2005.

DOI: https://doi.org/10.1080/00015550510032832

[15] M. K. A. Basra, M. S. Salek,… and A. Y. Finlay, "Conceptualization, development and validation of T‐QoL© (Teenagers' Quality of Life): a patient‐focused measure to assess quality of life of adolescents with skin diseases," British Journal of Dermatology, vol. 178, no. 1, pp. 161-175, 2018, doi: 10.1111/bjd.15853.

DOI: https://doi.org/10.1111/bjd.15853

[16] S. J. Whitehead and S. Ali, "Health outcomes in economic evaluation: the QALY and utilities," Br Med Bull, vol. 96, pp. 5-21, 2010, doi: 10.1093/bmb/ldq033.

DOI: https://doi.org/10.1093/bmb/ldq033

[17] G. Schmid-Ott, Schallmayer, S. and Calliess, I. T. , "Quality of life in patients with psoriasis andpsoriasis arthritis with a special focus on stigmatization experience," (in k), Clinics in dermatology, vol. 25, no. 6, pp. 547-554, 2007.

DOI: https://doi.org/10.1016/j.clindermatol.2007.08.008

[18] D. A. Stowers and Durm, M. W. , "Does self-concept depend on body image? A gender analysis," (in j), Psychological reports, vol. 78, no. 2, pp. 643-646, 1996.

DOI: https://doi.org/10.2466/pr0.1996.78.2.643

[19] R. Zachariae, Zachariae,…and Sigurgeirsson, B., "Quality of life in 6497 Nordic patients with psoriasis," (in i), British Journal of Dermatology, vol. 146, no. 6, pp. 1006-1016, 2002.

DOI: https://doi.org/10.1046/j.1365-2133.2002.04742.x

[20] Z. U. Bhatti, Salek, M. S. and Finlay, A. Y., "Chronic diseases influence major life changing decisions: a new domain in quality of life research," (in h), Journal of the Royal Society of Medicine, vol. 104, no. 6, pp. 241-250, 2011.

DOI: https://doi.org/10.1258/jrsm.2011.110010

[21] K. E. McKenna and Stern, R. S., "The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort," (in g), Journal of the American Academy of Dermatology, vol. 36, no. 3, pp. 388-394, 1997.

DOI: https://doi.org/10.1016/S0190-9622(97)80214-9

[22] D. G. Fortune, Main, C. J.,… and Griffiths, C. E. M., "Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis‐specific stress," (in f), British Journal of Dermatology, vol. 137, no. 5, pp. 755-760, 1997.

DOI: https://doi.org/10.1046/j.1365-2133.1997.19472062.x

[23] J. M. Gelfand, Feldman, S. R., Stern,… and Margolis, D. J., "Determinants of quality of life in patients with psoriasis: A study from the US population," (in e), Journal of the American Academy of Dermatology, vol. 51, no. 5, pp. 704-708, 2004.

DOI: https://doi.org/10.1016/j.jaad.2004.04.014

[24] Y. W. Lee, Park, E. J., Kwon,… and Kim, K. J., "Impact of psoriasis on quality of life: relationship between clinical response to therapy and change in health-related quality of life," (in d), Annals of dermatology, vol. 22, no. 4, pp. 389-396, 2010.

DOI: https://doi.org/10.5021/ad.2010.22.4.389